Pictet Asset Management (Switzerland)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $10.6M | Buy |
955,005
+260,368
| +37% | +$2.88M | 0.01% | 605 |
|
2023
Q1 | $9.33M | Buy |
694,637
+448,002
| +182% | +$6.02M | 0.01% | 626 |
|
2022
Q4 | $3.05M | Buy |
246,635
+63,529
| +35% | +$786K | ﹤0.01% | 847 |
|
2022
Q3 | $2.55M | Buy |
183,106
+25,813
| +16% | +$360K | ﹤0.01% | 875 |
|
2022
Q2 | $2.17M | Buy |
157,293
+14,768
| +10% | +$204K | ﹤0.01% | 925 |
|
2022
Q1 | $2.32M | Hold |
142,525
| – | – | ﹤0.01% | 941 |
|
2021
Q4 | $2.32M | Buy |
142,525
+36,202
| +34% | +$590K | ﹤0.01% | 973 |
|
2021
Q3 | $1.58M | Buy |
+106,323
| New | +$1.58M | ﹤0.01% | 1014 |
|